For More Information
Interested in learning about how Linical Americas can impact your next study?Learn More
Join Our investigator Network
Interested in becoming part of the Linical Americas Investigator network?Learn More
Linical's expert team has been providing Pharmacovigilance (PV) services since 2005, covering both clinical and postmarketing drugs and devices across several therapeutic areas. Our PV team provides a one-stop solution to identify and handle your safety management needs. We are a leading pharmacovigilance provider with global bandwidth for clinical safety management as well as postmarketing product inquiries, product complaints and adverse events. Linical uses cutting edge systems to enhance efficiency, ensure compliance, and help reduce the cost of safety data processing, and while delivering the hands-on, personalized service your project deserves.
Collecting and analyzing safety data is a crucial component of any clinical trial, seeing as clinical trials must establish safety as well as efficacy. It is critical that safety data is handled properly to ensure the accuracy of that data, achieve regulatory compliance, and safeguard patients.
Linical's team of seasoned professionals manage safety requirements for clinical trials across the globe and an extensive range of therapeutic areas. We use a powerful platform, ArisGlobal’s LifeSphere®, to ensure consistent safety processes across all studies and meet applicable regulatory deliverables. Our experienced staff of health care professionals and safety agents have a long tenure with our organization, providing our clients with consistency and stability. We work with you from start to finish, developing a Safety Management Plan and ensuring that your study meets regulatory requirements for safety as well as the highest medical and scientific standards.
Postmarketing surveillance is the process of monitoring the safety of an approved pharmaceutical drug or medical device subsequent to its release on the commercial market. Drugs and medical devices are approved on the basis of clinical trials, which involve relatively small numbers of individuals who may not have other medical conditions that can exist in the general population. Therefore, postmarketing surveillance can further refine, confirm, or define the safety of a drug or device after it is used in the general population by larger numbers of people with a wide variety of medical conditions.
Linical utilizes a number of approaches to monitor drug and device safety, including spontaneous reporting from health care professionals and consumers, reports from other pharmaceutical companies, reports identified in scientific literature as well as reports identified on monitored social media sites.
Linical's pharmacovigilance (PV) team is comprised of highly trained professionals and physicians who are fully committed to establishing and maintaining a close business relationship with our clients. We will work with you to develop a customized plan to meet your pharmacovigilance and safety surveillance needs and provide a dedicated project team who will meet your expectations for safety management in a professional, efficient, and cost-effective manner.
Linical uses ArisGlobal’s safety database (LifeSphere®) for pharmacovigilance case processing and report generation. The ArisGlobal safety database provides all of the functionality required to manage clinical and postmarketing safety management globally. Linical is equipped to handle Adverse Event reporting and adverse reaction requirements of different authorities around the world, from case entry to automatic generation of submission ready AE reports including MedWatch 3500A, CIOMS I, and many more.
Through modeling LifeSphere® within our organization, we can provide pharmacovigilance services to clients of all sizes, ranging from more customized safety processing services to higher volume, more automated data sets. We combine our pharmacovigilance team’s therapeutic expertise with LifeSphere’s® artificial intelligence (AI) and robotic process automation (RPA) to offer clients a cutting edge solution increasing compliance, reducing time to market, and controlling drug development costs. Not only does this provide benefits to our clients, but this also helps in our commitment to ensuring long term patient safety and corporate regulatory compliance.
Should there be a requirement for the transfer in or out of legacy data, our PV team will work closely with you and a third party to organize the project and ensure accuracy.
Learn more about how we can support your project or request a quote on our pharmacovigilance services. Contact Us.